EYEG

EyeGate Pharmaceuticals (EYEG) distributed dividends in the last year,in the months of January, February, March, April, May, June, July, August, September, October and November totaling $ 1.91. The Dividend Yield for the last 12 months is 0.25%.

Currently, EyeGate Pharmaceuticals (EYEG) is priced at $ 36.24, with a P/E of -24.37%, representando um desvio de -112% em relação ao seu P/L médio histórico. No último ano, a ação apresentou a variation of 6.35 in its price and distributed $ 1.91 in dividends, resulting in a Dividend Yield of 0.25%. The total shareholder return was 6.35%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Investing in stocks of EyeGate Pharmaceuticals (EYEG) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

The yield of EyeGate Pharmaceuticals (EYEG) was 0.01% in the last month, 6.35% in the last year and 1,113.39% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 2.06 in dividends, a Dividend Yield of 0.25%.

If you wanted to buy 100 stocks of EyeGate Pharmaceuticals (EYEG) today, the total investment would be $ 3,623.98, based on the current price of $ 36.24.

If past performance were to repeat, the return on your investment would be:

• In 1 year: $ 3,854.10
• In 5 years: $ 43,973.01
• In 10 years: $ 3,357.62

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.